COMMUNIQUÉS West-GlobeNewswire

Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of up to $33.5 Million in ARPA-H Funding to Advance Osteoarthritis Regenerative Therapies
06/04/2026
BOULDER, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for osteoarthritis, today announced its formal launch from [...]
Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
07/04/2026
Statistically significant (p<0.0477) DFU wound closure at 12 weeks RCT compared PuraPly®AM plus standard of care to standard of care alone Results strengthen existing clinical evidence supporting future coverage [...]
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
07/04/2026
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides a market update on its commercial and operational performance for the [...]
Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026
06/04/2026
PETACH TIKVA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]
Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
06/04/2026
EPO Greenlights Claims Covering Preventative use of therapy targeting 5-HT4 Pathway and Expands Silo Pharma IP Portfolio SARASOTA, FL, April 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “ [...]
Neuronetics Announces Chief Financial Officer Transition
06/04/2026
Reaffirms Fiscal Year 2026 Financial Guidance MALVERN, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and [...]
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/04/2026
NEW YORK and WALTHAM, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Avicanna Announces Changes to its Board of Directors
06/04/2026
TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and [...]
Cytokinetics to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
SOUTH SAN FRANCISCO, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at [...]
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
06/04/2026
- YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now commercially available in the U [...]
Outset Medical Names Derick Elliott as Executive Vice President of Commercial
06/04/2026
SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and [...]
Metabo Drops Claims Evaluated: Recent Investigation Into MetaboDrops Official Website Announcement
06/04/2026
A 2026 informational overview of Metabo Drops coffee metabolism drop marketing claims, proprietary blend label disclosures, ingredient dosage research context, pricing structure, 60-day guarantee terms, and what men and [...]
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that Ben [...]
Glyco Harmony Drops Claims Evaluated: Explore the Official Gluco Harmony Glycogen Support Website Facts
06/04/2026
A 2026 informational overview of Glyco Harmony blood sugar support drops, chromium picolinate and proprietary blend ingredient disclosures, liquid supplement formulation details, and what the official Glyco Harmony [...]
GlucoZen Claim Evaluated: Highly-Effective Blood Sugar Support for Natural Glucose Harmony
06/04/2026
A 2026 consumer informational overview of GlucoZen's blood sugar support ingredient research, glucose harmony positioning, pricing and guarantee details, and what adults exploring natural metabolic support options [...]
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
06/04/2026
Clinical Development Program Appropriate for Rolling BLA Submission Expected by the End of 2025 CANTON, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative [...]
DIBS AI Unveils Version 9.0 Platform Suite to Streamline Orthodontic Workflows
06/04/2026
Three AI-driven platforms improve efficiency, predictability, and turnaround times—delivered at $165 per case AMERICAN FORK, Utah, April 06, 2026 (GLOBE NEWSWIRE) -- DIBS AI ® , a division of OrthoSelect, announces the [...]
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
06/04/2026
Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing LOUISVILLE, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. ( [...]
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
FOSTER CITY, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that [...]

Pages